Literature DB >> 27639564

Cross sectional and nuclear medicine imaging of pancreatic insulinomas.

Sampanna Jung Rayamajhi1, Jeff Lee2, Bhagwant Rai Mittal3, Aaron Craig Jessop4, Beth Chasen5, Priya Bhosale6.   

Abstract

Insulinomas are rare neuroendocrine tumors which occur predominantly in the pancreas. Although majority of the insulinomas are benign, over-secretion of insulin by the tumor leads to debilitating hypoglycemic symptoms. The diagnosis is based on clinical and biochemical findings. After the diagnosis is made, the principal challenge lies in locating the tumor because most tumors are solitary and small in size. Locating the tumor is of paramount importance as complete surgical excision is the only curative treatment, and incomplete resection leads to persistence of symptoms. Different preoperative and intraoperative imaging techniques have been used with varying success rates for the insulinoma imaging. Besides localizing the tumor, imaging also helps to guide biopsy, detect metastatic lesions, and perform image-guided therapeutic procedures. This review will discuss the role of different Cross sectional and nuclear medicine imaging modalities in insulinomas.

Entities:  

Keywords:  68Ga-DOTATATE; 68Ga-exendin; Endoscopic ultrasonography; Insulinoma; Nuclear medicine imaging

Mesh:

Substances:

Year:  2017        PMID: 27639564     DOI: 10.1007/s00261-016-0904-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  2 in total

Review 1.  Exendin-4 analogs in insulinoma theranostics.

Authors:  Tom J P Jansen; Sanne A M van Lith; Marti Boss; Maarten Brom; Lieke Joosten; Martin Béhé; Mijke Buitinga; Martin Gotthardt
Journal:  J Labelled Comp Radiopharm       Date:  2019-08       Impact factor: 1.921

2.  Changing Insulinoma Management Due to Incidentally Discovered Metastasis: A Case Report.

Authors:  Riya Madan; Tetyana Mettler; Jerry Froelich; Lisa S Chow
Journal:  Am J Case Rep       Date:  2020-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.